Patients with any recurrence including local, locoregional, and distant tumors/metastases had significantly poorer OS (Fig. S7C; HR: 2.51, 95% CI: 1.02–6.21, P = 0.039) and expressed higher levels of SLUG protein in the index carcinoma compared with patients without any recurring tumor over five years of clinical follow‐up (Fig. 6B). The gene discussed is SNAI2; the disease is carcinoma.